Purpose: To report a case of an immunocompetent 64-year-old man who developed cytomegalovirus (CMV) retinitis after using topical difluprednate. Observations: A 64-year-old man with type 2 diabetes developed hemorrhagic retinitis while using topical difluprednate after penetrating keratoplasty. Polymerase chain reaction of the vitreous was positive for CMV DNA. Complete blood count was within normal limits and 4th generation human immunodeficiency virus assay was negative. The retinitis resolved with oral valgancyclovir and intravitreal foscarnet injections. Conclusion and importance: CMV retinitis may occur after topical difluprednate in an immunocompetent patient.
|Journal||American Journal of Ophthalmology Case Reports|
|State||Published - Dec 2019|
- Cytomegalovirus retinitis
- Topical steroid